PON2
Serum paraoxonase/arylesterase 2
Also known as: PON2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15165
- Gene
- PON2
- Ensembl
- ENSG00000105854
- Chromosome
- 7
- Canonical length
- 354 aa
- Protein class
- Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
This gene encodes a member of the paraoxonase gene family, which includes three known members located adjacent to each other on the long arm of chromosome 7. The encoded protein is ubiquitously expressed in human tissues, membrane-bound, and may act as a cellular antioxidant, protecting cells from oxidative stress. Hydrolytic activity against acylhomoserine lactones, important bacterial quorum-sensing mediators, suggests the encoded protein may also play a role in defense responses to pathogenic bacteria. Mutations in this gene may be associated with vascular disease and a number of quantitative phenotypes related to diabetes. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>Q15165|PON2
1 MGRLVAVGLL GIALALLGER LLALRNRLKA SREVESVDLP HCHLIKGIEA GSEDIDILPN
61 GLAFFSVGLK FPGLHSFAPD KPGGILMMDL KEEKPRAREL RISRGFDLAS FNPHGISTFI
121 DNDDTVYLFV VNHPEFKNTV EIFKFEEAEN SLLHLKTVKH ELLPSVNDIT AVGPAHFYAT
181 NDHYFSDPFL KYLETYLNLH WANVVYYSPN EVKVVAEGFD SANGINISPD DKYIYVADIL
241 AHEIHVLEKH TNMNLTQLKV LELDTLVDNL SIDPSSGDIW VGCHPNGQKL FVYDPNNPPS
301 SEVLRIQNIL SEKPTVTTVY ANNGSVLQGS SVASVYDGKL LIGTLYHRAL YCELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PON2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 229 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 229 nTPM
- amygdala: 205 nTPM
- cerebral cortex: 185 nTPM
- liver: 172 nTPM
- midbrain: 160 nTPM
- hippocampal formation: 135 nTPM
Single-cell type
- bergmann glia: 476 nCPM
- extravillous trophoblasts: 468 nCPM
- astrocytes: 458 nCPM
- myosatellite cells: 352 nCPM
- alveolar cells type 1: 319 nCPM
- alveolar cells type 2: 245 nCPM
Immune cell
- myeloid DC: 34 nTPM
- NK-cell: 8.9 nTPM
- plasmacytoid DC: 8.2 nTPM
- classical monocyte: 7.8 nTPM
- gdT-cell: 5 nTPM
- MAIT T-cell: 4.6 nTPM
Brain region
- hypothalamus: 164 nTPM
- basal ganglia: 152 nTPM
- white matter: 147 nTPM
- thalamus: 139 nTPM
- midbrain: 136 nTPM
- amygdala: 132 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.03
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.76
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- acyl-L-homoserine-lactone lactonohydrolase activity
- arylesterase activity
- metal ion binding
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PON2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PON2 as an antibody target. Whether an autoantibody or antibody against PON2 could matter depends on whether native PON2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PON2 is annotated at the cell surface, where native PON2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PON2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...